男性无关供者与经产妇同胞供者移植受者的移植物抗宿主病比较
该回顾性队列研究利用国际血液与骨髓移植研究中心登记库,纳入2000至2012年间接受T细胞充足移植的急性髓系白血病、急性淋巴细胞白血病或骨髓增生异常综合征成人患者,比较经产妇同胞供者与男性无关供者移植的GVHD及生存结局。结果显示男性无关供者移植的2至4级急性GVHD风险更高,女性受者接受男性无关供者移植的慢性GVHD风险也更高,其他终点无显著差异。作者结论为若有经产妇同胞供者,优先于男性无关供者。
要点
- 男性无关供者移植的2至4级急性GVHD风险是经产妇同胞供者移植的1.6倍(P<.0001)。
- 女性受者接受男性无关供者移植的慢性GVHD风险高于经产妇同胞供者移植(RR=1.43,P<.0001)。
- 男性受者两种供者类型的慢性GVHD发生率相似(RR=1.09,P=.23)。
核心结论
- 作者结论为若有经产妇同胞供者,优先于男性无关供者。
研究设计与样本
- 利用国际血液与骨髓移植研究中心登记库开展的回顾性队列研究,纳入2000至2012年间接受T细胞充足移植的急性髓系白血病、急性淋巴细胞白血病或骨髓增生异常综合征成人患者,比较经产妇同胞供者与男性无关供者两种供者类型。
- 共纳入2813例受者,其中接受男性无关供者移植者1921例。
主要发现
- 接受男性无关供者移植的患者2至4级急性GVHD风险为经产妇同胞供者移植的1.6倍(P<.0001)。
- 女性受者接受男性无关供者移植的慢性GVHD风险高于经产妇同胞供者移植(RR=1.43,P<.0001)。
- 男性受者两种供者类型的慢性GVHD发生率相似(RR=1.09,P=.23)。
- 供者类型对无病生存、移植相关死亡、复发及总生存等其他终点均无显著影响。
临床怎么用
- 作者认为若有经产妇同胞供者,优先于男性无关供者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Optimal donor selection is critical for successful allogeneic hematopoietic cell transplantation (HCT). Donor sex and parity are well-established risk factors for graft-versus-host disease (GVHD), with male donors typically associated with lower rates of GVHD. Well-matched unrelated donors (URDs) have also been associated with increased risks of GVHD as compared with matched sibling donors. These observations raise the question of whether male URDs would lead to more (or less) favorable transplant outcomes as compared with parous female sibling donors. We used the Center for International Blood and Marrow Transplant Research registry to complete a retrospective cohort study in adults with acute myeloid leukemia, acute lymphoblastic leukemia, or myelodysplastic syndrome, who underwent T-cell replete HCT from these 2 donor types (parous female sibling or male URD) between 2000 and 2012. Primary outcomes included grade 2 to 4 acute GVHD (aGVHD), chronic GVHD (cGVHD), and overall survival. Secondary outcomes included disease-free survival, transplant-related mortality, and relapse. In 2813 recipients, patients receiving male URD transplants (n = 1921) had 1.6 times higher risk of grade 2 to 4 aGVHD (P < .0001). For cGVHD, recipient sex was a significant factor, so donor/recipient pairs were evaluated. Female recipients of male URD grafts had a higher risk of cGVHD than those receiving parous female sibling grafts (relative risk [RR] = 1.43, P < .0001), whereas male recipients had similar rates of cGVHD regardless of donor type (RR = 1.09, P = .23). Donor type did not significantly affect any other end point. We conclude that when available, parous female siblings are preferred over male URDs.
引用
- Kumar AJ, Kim S, Hemmer MT, et al. Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants. Blood Adv. 2018. PMID: 29739773. doi:10.1182/bloodadvances.2017013052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。